logo

Last Update

This profile was last updated on 8/1/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Laurie Keating?

Laurie B. Keating

Senior Vice President, General Counsel and Secretary

Alnylam Pharmaceuticals , Inc.

HQ Phone:  (617) 551-8200

Direct Phone: (617) ***-****direct phone

Email: l***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Alnylam Pharmaceuticals , Inc.

300 Third Street 3Rd Floor

Cambridge, Massachusetts,02142

United States

Company Description

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines. Alnylam's pipeline of investigational RNAi therapeutics is focused i...more

Background Information

Employment History

Executive

Sybase Inc


Senior Vice President, General Counsel and Secretary

Iomega Corporation


Affiliations

Millennium Pharmaceuticals , Inc.

Senior Vice President, General Counsel, and Secretary


Hydra Biosciences Inc

Chief Executive Officer


MassBio

Board Member


Massachusetts Biotechnology Council Inc

Board Member


Biotechnology Industry Organization

Chair of the General Counsel's Committee


Education

Hastings College of Law


J.D.

University of California


bachelor's degree

Economics

University of California at Berkeley


Web References(76 Total References)


www.sec.gov


0001620743 KEATING LAURIE 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, GC & Secretary


www.alnylam.com [cached]

Laurie Keating, JD
SVP, General Counsel, and Secretary Laurie Bartlett Keating joined Alnylam in 2014 with more than 25 years of executive experience at high technology and biotechnology companies. Prior to joining Alnylam, Laurie served as Senior Vice President, General Counsel and Secretary of Millennium: The Takeda Oncology Company for 9 years, responsible for setting the company's global legal, intellectual property, and corporate quality strategies and priorities. Prior to Millennium, Laurie was co-founder and the first CEO of Hydra Biosciences, Inc. Before co-founding Hydra, she served as an executive at high-growth technology companies, including Iomega Corporation, and Sybase, Inc., a software company that grew from a few hundred to 6,000 employees during Laurie's tenure on the management team. Based on her leadership at Sybase, Laurie was named one of the 45 most influential in-house lawyers in the United States under the age of 45. Upon graduating from law school, Laurie practiced law at McCutchen, Doyle, Brown and Enersen (now Bingham McCutchen) in San Francisco. She has a Doctor of Jurisprudence degree from the University of California, Hastings College of the Law, and a BA in Economics from the University of California at Berkeley. Laurie is a member of the Board of Directors of MassBio, and the immediate past chair of the BIO General Counsels Committee.


investors.alnylam.com [cached]

Laurie Keating
SVP, General Counsel and Secretary Laurie Bartlett Keating joined Alnylam in 2014 with more than 25 years of executive experience at high technology and biotechnology companies. Prior to joining Alnylam, Laurie served as Senior Vice President, General Counsel and Secretary of Millennium: The Takeda Oncology Company for 9 years, responsible for setting the company's global legal, intellectual property, and corporate quality strategies and priorities. Prior to Millennium, Laurie was co-founder and the first CEO of Hydra Biosciences, Inc. Before co-founding Hydra, she served as an executive at high growth technology companies, including serving as Senior Vice President, General Counsel and Secretary of Iomega Corporation, and Sybase, Inc., a software company that grew from a few hundred to 6,000 employees during Laurie's tenure on the management team. Based on her leadership at Sybase, she was named as one of the 45 most influential in-house lawyers in the United States under the age of 45. Upon graduating from law school, Laurie practiced law at McCutchen, Doyle, Brown and Enersen (now Bingham McCutchen) in San Francisco. She has a Doctor of Jurisprudence from the University of California, Hastings College of the Law, and a Bachelor of Arts in Economics from the University of California at Berkeley. Laurie is a member of the Board of Directors of MassBio and the immediate past chair of the BIO General Counsels Committee.


www.mmm-online.com [cached]

Laurie Keating has served as Alnylam's Senior Vice President, General Counsel and Corporate Secretary, with global responsibility for Legal, Intellectual Property, Government Relations/Public Policy, and Ethics & Compliance, since September 2014.
Prior to joining Alnylam, she served as Senior Vice President, General Counsel and Corporate Secretary of Millennium Pharmaceuticals from 2004 to 2014, with responsibility for Legal, Intellectual Property, Quality and Compliance. Prior to Millennium, Ms. Keating was co-founder, the first CEO and a member of the Board of Directors of Hydra Biosciences, a venture-backed research stage company whose investors include Polaris, Abingworth, NEA, ATV and Lilly. Before co-founding Hydra, she served as an executive at several high growth technology companies, including Sybase which went public and grew from approximately 400 to 6,000 employees during the time that she was a member of the executive team. Based on her leadership at Sybase, she was named one of the 45 most influential in-house lawyers in the U.S. under the age of 45. Earlier in her career, Ms. Keating practiced law at McCutchen, Doyle, Brown and Enersen (now part of Morgan, Lewis & Bockius). Laurie is a member of the Board of Directors of MassBIO and a past chair of the BIO General Counsel's Committee. During 2015-16 she was a member of the biopharmaceutical industry team that negotiated a new Prescription Drug User Fee Agreement (PDUFA VI) with the FDA. Legislation to enact PDUFA VI is now pending in Congress. Laurie earned a bachelors degree in Economics from the University of California at Berkeley, Laurie Keating SVP, general counsel & secretary, Alnylam Pharmaceuticals Laurie Keating, SVP, general counsel & secretary, Alnylam Pharmaceuticals Laurie Keating has served as Alnylam's Senior Vice President, General Counsel and Corporate Secretary, with global responsibility for Legal, Intellectual Property, Government Relations/Public Policy, and Ethics & Compliance, since September 2014. Prior to joining Alnylam, she served as Senior Vice President, General Counsel and Corporate Secretary of Millennium Pharmaceuticals from 2004 to 2014, with responsibility for Legal, Intellectual Property, Quality and Compliance. Prior to Millennium, Ms. Keating was co-founder, the first CEO and a member of the Board of Directors of Hydra Biosciences, a venture-backed research stage company whose investors include Polaris, Abingworth, NEA, ATV and Lilly. Before co-founding Hydra, she served as an executive at several high growth technology companies, including Sybase which went public and grew from approximately 400 to 6,000 employees during the time that she was a member of the executive team. Based on her leadership at Sybase, she was named one of the 45 most influential in-house lawyers in the U.S. under the age of 45. Earlier in her career, Ms. Keating practiced law at McCutchen, Doyle, Brown and Enersen (now part of Morgan, Lewis & Bockius). Laurie is a member of the Board of Directors of MassBIO and a past chair of the BIO General Counsel's Committee. During 2015-16 she was a member of the biopharmaceutical industry team that negotiated a new Prescription Drug User Fee Agreement (PDUFA VI) with the FDA. Legislation to enact PDUFA VI is now pending in Congress. Laurie earned a bachelors degree in Economics from the University of California at Berkeley,


www.alnylam.com [cached]

Laurie Keating
Laurie Keating, SVP, General Counsel, and Secretary Laurie Bartlett Keating joined Alnylam in 2014 with more than 25 years of executive experience at high technology and biotechnology companies. Prior to joining Alnylam, Laurie served as Senior Vice President, General Counsel and Secretary of Millennium: The Takeda Oncology Company for 9 years, responsible for setting the company's global legal, intellectual property, and corporate quality strategies and priorities. Prior to Millennium, Laurie was co-founder and the first CEO of Hydra Biosciences, Inc. Before co-founding Hydra, she served as an executive at high growth technology companies, including serving as Senior Vice President, General Counsel and Secretary of Iomega Corporation, and Sybase, Inc., a software company that grew from a few hundred to 6,000 employees during Laurie's tenure on the management team. Based on her leadership at Sybase, she was named as one of the 45 most influential in-house lawyers in the United States under the age of 45. Upon graduating from law school, Laurie practiced law at McCutchen, Doyle, Brown and Enersen (now Bingham McCutchen) in San Francisco. She has a Doctor of Jurisprudence from the University of California, Hastings College of the Law, and a Bachelor of Arts in Economics from the University of California at Berkeley. Laurie is a member of the Board of Directors of MassBio and the immediate past chair of the BIO General Counsels Committee.Close Bio


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory